» Articles » PMID: 35256717

A Novel Streptococcus Pneumoniae Human Challenge Model Demonstrates Treg Lymphocyte Recruitment to the Infection Site

Overview
Journal Sci Rep
Specialty Science
Date 2022 Mar 8
PMID 35256717
Authors
Affiliations
Soon will be listed here.
Abstract

To investigate local tissue responses to infection we have developed a human model of killed Streptococcus pneumoniae challenge by intradermal injection into the forearm. S. pneumoniae intradermal challenge caused an initial local influx of granulocytes and increases in TNF, IL6 and CXCL8. However, by 48 h lymphocytes were the dominant cell population, mainly consisting of CD4 and CD8 T cells. Increases in local levels of IL17 and IL22 and the high proportion of CD4 cells that were CCR6 suggested a significant Th17 response. Furthermore, at 48 h the CD4 population contained a surprisingly high proportion of likely memory Treg cells (CCR6 positive and CD45RA negative CD4CD25CD127 cells) at 39%. These results demonstrate that the intradermal challenge model can provide novel insights into the human response to S. pneumoniae and that Tregs form a substantial contribution of the normal human lymphocyte response to infection with this important pathogen.

Citing Articles

The translational potential of inflammation-induced skin blister human models in exploring the pathogenesis of periodontitis and its systemic health implications.

Irwandi R, Marruganti C, Collins G, de Souza Carvalho J, Gilroy D, DAiuto F Front Immunol. 2024; 15:1469828.

PMID: 39737182 PMC: 11682961. DOI: 10.3389/fimmu.2024.1469828.


Lipidation of pneumococcal proteins enables activation of human antigen-presenting cells and initiation of an adaptive immune response.

Paulikat A, Schwudke D, Hammerschmidt S, Voss F Front Immunol. 2024; 15:1392316.

PMID: 38711516 PMC: 11070533. DOI: 10.3389/fimmu.2024.1392316.

References
1.
Musher D . Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin Infect Dis. 1992; 14(4):801-7. DOI: 10.1093/clinids/14.4.801. View

2.
Ferreira D, Neill D, Bangert M, Gritzfeld J, Green N, Wright A . Controlled human infection and rechallenge with Streptococcus pneumoniae reveals the protective efficacy of carriage in healthy adults. Am J Respir Crit Care Med. 2013; 187(8):855-64. PMC: 3707375. DOI: 10.1164/rccm.201212-2277OC. View

3.
Weight C, Venturini C, Pojar S, Jochems S, Reine J, Nikolaou E . Microinvasion by Streptococcus pneumoniae induces epithelial innate immunity during colonisation at the human mucosal surface. Nat Commun. 2019; 10(1):3060. PMC: 6635362. DOI: 10.1038/s41467-019-11005-2. View

4.
McCool T, Cate T, Moy G, Weiser J . The immune response to pneumococcal proteins during experimental human carriage. J Exp Med. 2002; 195(3):359-65. PMC: 2193593. DOI: 10.1084/jem.20011576. View

5.
Collins A, Wright A, Mitsi E, Gritzfeld J, Hancock C, Pennington S . First human challenge testing of a pneumococcal vaccine. Double-blind randomized controlled trial. Am J Respir Crit Care Med. 2015; 192(7):853-8. DOI: 10.1164/rccm.201503-0542OC. View